New book by Larry Connors Click here Improve your trading - See how
Flamel Technologies S.A. (NASDAQ: FLML | Quote | Chart | News | PowerRating) a biopharmaceutical company, develops polymer-based drug delivery technologies for the improvement of medical applications in France. It offers Interferon-Alpha XL, an interferon-alpha 2b for the treatment of hepatitis C virus and various oncology applications; FT-105, a long-acting basal insulin formulation for diabetic patients; and Interleukin-2 for the treatment of renal cancer. The company also provides Coreg CR, an extended release formulation of carvedilol phosphate for use in the treatment of congestive heart failure, left ventricular dysfunction following myocardial infarction, and hypertension; and Asacard162.5mg, a controlled release formulation of aspirin designed to provide therapy for cardiovascular treatment. The company has strategic alliances with GlaxoSmithKline, Merck Serono, Wyeth Pharmaceuticals, TAP Pharmaceuticals, Ltd., Bristol-Myers Squibb, Biovail, Servier, Merck & Co., Corning S.A., Corning Incorporated, and Corning Europe, Inc. Flamel Technologies was founded in 1990 and is headquartered in Venissieux, France. With 24.05 million shares outstanding and 6.11 million shares declared short as of May 2008, there is a failure to deliver in shares of FLML. According to quarterly data provided by the SEC, there were still 18,780 shares of FLML that were failing-to-deliver as of September 27, 2007.
GeoResources Inc. (NASDAQ: GEOI | Quote | Chart | News | PowerRating) engages in the acquisition, development, and production of crude oil, natural gas, and related products primarily in Texas, Louisiana, North Dakota, Montana, and Colorado. The company holds interests primarily in the Black Warrior Basin Fields located in Alabama and Mississippi; the Chittim Field located in Maverick County, Texas; the Driscoll Field located in Duval County, Texas; the Eloi Bay Field complex located in state waters offshore St. Bernard Parish, Louisiana; the Frisco and Fordoche Fields located in Pointe Coupee Parish, Louisiana; and the Giddings Field located in Brazos, Burleson, Fayette, Grimes, Lee, and Washington Counties, Texas. It also owns interest in the Harris Field located in Gaines County, Texas; the Landa Field located in Bottineau County, North Dakota; the MAK Field located in Andrews County, Texas; the New Mexico Fields located in Eddy and Lea Counties, New Mexico; the Odem Field located in San Patricio County, Texas; and the Quarantine Bay Field located in State waters offshore Plaquemines Parish, Louisiana. In addition, the company holds interests in the Sherman/Wayne Fields located in Bottineau County, North Dakota; the St. Martinville Field located in St. Martin Parish, Louisiana; and the Starbuck Field located in Bottineau County, North Dakota. As of December 31, 2007, GeoResources, Inc. had estimated proved reserves of approximately 10,744,079 bbls of oil; and 29,810,318 mcf of gas. It had total net acreage of approximately 151,515 developed acres; and 56,689 undeveloped acres. The company was founded in 2004 and is headquartered in Houston, Texas. With 14.7 million shares outstanding and 185,400 shares declared short as of May 2008, there is a failure to deliver in shares of GEOI.
LJ International Inc. (NASDAQ: JADE | Quote | Chart | News | PowerRating) together with its subsidiaries, engages in the design, manufacture, marketing, and sale of precious and color gemstones, as well as diamond jewelry. The company offers colored jewelry, which includes pieces set in yellow gold, white gold, platinum, or sterling silver; and adorned with colored stones, diamonds, pearls, and precious stones. Its product line includes earrings, necklaces, pendants, rings, and bracelets. The company distributes its products to fine jewelers, department stores, national jewelry chains, and electronic and specialty retailers in North America and Western Europe. It also involves in the retail of jewelry through the ENZO brand in the Asia Pacific region. As of June 11, 2008, the company operated 98 ENZO retail stores across Hong Kong, China, and Macau. In addition, it owns commercial and residential properties in Hong Kong, which are held primarily for lease. The company was founded in 1987 and is based in Hung Hom, Hong Kong. With 21.44 million shares outstanding and 897,100 shares declared short as of May 2008, there is a failure to deliver in shares of JADE. According to quarterly data provided by the SEC, there were still 37,673 shares of JADE that were failing-to-deliver as of September 12, 2007.
Lamar Advertising Company (NASDAQ: LAMR | Quote | Chart | News | PowerRating) together with its subsidiaries, provides outdoor advertising services in the United States, Canada, and Puerto Rico. It offers outdoor advertising displays, such as billboards, including bulletins and posters; logo signs; and transit advertising displays. The company offers its services to restaurants, retailers, automotive, real estate companies, health care, gaming, service, hotels and motels, telecommunications, and amusement industries. As of December 31, 2007, it owned and operated approximately 151,000 billboard advertising displays in 44 states, Canada, and Puerto Rico; approximately 100,000 logo advertising displays in 19 states and the province of Ontario, Canada; and approximately 28,500 transit advertising displays in 17 states, Canada, and Puerto Rico. The company was founded in 1989 and is headquartered in Baton Rouge, Louisiana. With 92.36 million shares outstanding and 19.75 million shares declared short as of May 2008, there is a failure to deliver in shares of LAMR. According to quarterly data provided by the SEC, there were still 71,365 shares of LAMR that were failing-to-deliver as of September 26, 2007.
New Oriental Energy & Chemical Corp. (NASDAQ: NOEC | Quote | Chart | News | PowerRating) through its subsidiary, Henan Jinding Chemical Co., Ltd., engages in the manufacture and distribution of fertilizer and chemical products in the People's Republic of China. It offers urea and coal-based chemicals, including ammonium bicarbonate and liquid ammonia for nitrogenous fertilizers and raw materials of chemical products; methanol, which is used for the production of medicine, pesticide, dye, plastic, synthetic protein, fiber, formaldehyde, and methyl ether; and dimethyl ether that is used as an additive for liquefied petroleum gas (LPG) and non-industrial fuel substitute to LPG and for residential and automotive uses, and as refrigerant for refrigerators and air conditioners. The company serves chemical, pharmaceutical, light, and textile industries. New Oriental sells its products primarily through regional distributors. The company was incorporated in 2003 and is based in Xinyang, the People's Republic of China. With 12.64 million shares outstanding and 272,900 shares declared short as of May 2008, there is a failure to deliver in shares of NOEC. According to quarterly data provided by the SEC, there were still 11,860 shares of NOEC that were failing-to-deliver as of September 28, 2007.
ZymoGenetics Inc. (NASDAQ: ZGEN | Quote | Chart | News | PowerRating) a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases primarily hemostasis, inflammatory and autoimmune diseases, cancer, and viral infections. It principally markets RECOTHROM, a recombinant thrombin, which is a topical hemostatic agent used for the control of moderate bleeding during surgical procedures. The company's product candidates in clinical development include atacicept, which is intended for the treatment of systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, multiple myeloma, non-Hodgkin's lymphoma, and chronic lymphocytic leukemia; IL-21, which is intended for the treatment of metastatic melanoma, metastatic renal cell carcinoma, non-Hodgkin's lymphoma, colorectal cancer, and ovarian cancer; PEG-IFN-l for the treatment of hepatitis C virus infection and multiple sclerosis; IL-17RC for the treatment of inflammatory diseases; and IL-31 mAb for the treatment of atopic dermatitis and inflammatory diseases. It also offers out-licensed commercial products comprising Novolin and insulin analogs for diabetes; NovoSeven for the treatment of hemophilia; Regranex for wound healing; GEM 21S for periodontal defects; GlucaGen for hypoglycemia and gastrointestinal motility inhibition; and Cleactor for treatment of myocardial infarction. The company's out-licensed product candidates include GEM-OS1/GEM-OS2 for the treatment of orthopedic fracture and other bone defects; rFactor XIII for the treatment of congenital factor XIII deficiency, cardiac surgery, and cancer treatment; FGF-18 for the treatment of osteoarthritis; and IL-20 and IL-22 receptor, which are intended for the treatment of psoriasis. It has collaborative agreements with Novo Nordisk A/S; Merck Serono S.A.; Bayer Schering Pharma AG; and Bayer HealthCare LLC. The company was founded in 1981 and is headquartered in Seattle, Washington. With 68.7 million shares outstanding and 12.06 million shares declared short as of May 2008, there is a failure to deliver in shares of ZGEN. According to quarterly data provided by the SEC, there were still 42,313 shares of ZGEN that were failing-to-deliver as of September 28, 2007.
About BUYINS.NET
WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.
BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted, www.buyins.net/squeezetrigger.pdf. The SqueezeTrigger database of nearly 2,050,000,000 short sale transactions goes back to January 1, 2005, and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005, because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each month's short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money.
All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET may receive compensation in cash or shares from independent third parties or from the companies mentioned.
BUYINS.NET affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value. Market commentary provided by Thomas Ronk.
BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.
You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.
CONTACT: Thomas Ronk, CEO, BUYINS.NET Tel: +1 800 715 9999 e-mail: Tom@buyins.net WWW: http://www.buyins.net
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
15260 Ventura Blvd., Ste. 2200
Sherman Oaks, CA 91403
© Copyright 2009 The Connors Group, Inc.
